Terms: = Colorectal cancer AND IL6ST, CDw130, 3572, ENSG00000134352, P40189, IL6R-beta, GP130-RAPS, GP130, CD130 AND Prognosis
3 results:
1. [Clinicopathological features and prognosis in patients with presacral recurrent rectal cancer].
Wang C; Guo P; Yang XD; Xie QW; Yin MJ; Jiang KW; Liang B; Shen ZL; Shen K; Wang S; Ye YJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):461-465. PubMed ID: 32842425
[No Abstract] [Full Text] [Related]
2. RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.
Cross-Knorr S; Lu S; Perez K; Guevara S; Brilliant K; Pisano C; Quesenberry PJ; Resnick MB; Chatterjee D
BMC Cancer; 2013 Oct; 13():463. PubMed ID: 24098947
[TBL] [Abstract] [Full Text] [Related]
3. Interleukin-6 (IL-6) released by macrophages induces IL-6 secretion in the human colon cancer HT-29 cell line.
Li YY; Hsieh LL; Tang RP; Liao SK; Yeh KY
Hum Immunol; 2009 Mar; 70(3):151-8. PubMed ID: 19272324
[TBL] [Abstract] [Full Text] [Related]
